Literature DB >> 24820032

Ovalbumin-coated pH-sensitive microneedle arrays effectively induce ovalbumin-specific antibody and T-cell responses in mice.

Koen van der Maaden1, Eleni Maria Varypataki2, Stefan Romeijn1, Ferry Ossendorp3, Wim Jiskoot1, Joke Bouwstra4.   

Abstract

The aim of this work was to study the applicability of antigen-coated pH-sensitive microneedle arrays for effective vaccination strategies. Therefore, a model antigen (ovalbumin) was coated onto pH-sensitive (pyridine-modified) microneedle arrays to test pH-triggered antigen release by applying the coated arrays onto ex vivo human skin, and by conducting a dermal immunization study in mice. The release of antigen into ex vivo human skin from the coated microneedles was determined by using radioactively labeled ovalbumin. To investigate the induction of antigen-specific IgG, and CD4(+) and CD8(+) T-cell responses, BALB/c mice were immunized with antigen-coated pH-sensitive microneedles by the 'coat and poke' approach. These responses were compared to responses induced by the 'poke and patch' approach, and subcutaneous and intradermal vaccination with classic hypodermic needles. The pH-sensitive microneedle arrays were efficiently coated with ovalbumin (95% coating efficiency) and upon application of six microneedle arrays 4.27 of 7 μg ovalbumin was delivered into the skin, showing a release efficiency of 70%. In contrast, the 'poke and patch' approach led to a delivery of only 6.91 of 100 μg ovalbumin (7% delivery efficiency). Immunization by means of ovalbumin-coated microneedles resulted in robust CD4(+) and CD8(+) T-cell responses comparable to those obtained after subcutaneous or intradermal immunization with conventional needles. Moreover, it effectively induced IgG responses; however, it required prime-boost immunizations before antibodies were produced. In conclusion, antigen delivery into ex vivo human skin by antigen-coated pH-sensitive microneedle arrays is more efficient than the 'poke-and-patch' approach and in vivo vaccination studies show the applicability of pH-sensitive microneedles for the induction of both T cell and B cell responses.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dermal immunization; Functional coatings; Microneedles; Minimally-invasive drug delivery; Transdermal drug delivery; pH-triggered delivery

Mesh:

Substances:

Year:  2014        PMID: 24820032     DOI: 10.1016/j.ejpb.2014.05.003

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  10 in total

Review 1.  Microneedle Coating Methods: A Review with a Perspective.

Authors:  Rohan S J Ingrole; Harvinder Singh Gill
Journal:  J Pharmacol Exp Ther       Date:  2019-06-07       Impact factor: 4.030

Review 2.  Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery: Current Understandings and Clinical Translation.

Authors:  Hanhee Cho; Seong Ik Jeon; Cheol-Hee Ahn; Man Kyu Shim; Kwangmeyung Kim
Journal:  Pharmaceutics       Date:  2022-03-28       Impact factor: 6.525

Review 3.  Microneedle-based drug and vaccine delivery via nanoporous microneedle arrays.

Authors:  Koen van der Maaden; Regina Luttge; Pieter Jan Vos; Joke Bouwstra; Gideon Kersten; Ivo Ploemen
Journal:  Drug Deliv Transl Res       Date:  2015-08       Impact factor: 4.617

4.  Mesoporous Silica Nanoparticle-Coated Microneedle Arrays for Intradermal Antigen Delivery.

Authors:  Jing Tu; Guangsheng Du; M Reza Nejadnik; Juha Mönkäre; Koen van der Maaden; Paul H H Bomans; Nico A J M Sommerdijk; Bram Slütter; Wim Jiskoot; Joke A Bouwstra; Alexander Kros
Journal:  Pharm Res       Date:  2017-05-23       Impact factor: 4.200

5.  In Vivo Expansion of Melanoma-Specific T Cells Using Microneedle Arrays Coated with Immune-Polyelectrolyte Multilayers.

Authors:  Qin Zeng; Joshua M Gammon; Lisa H Tostanoski; Yu-Chieh Chiu; Christopher M Jewell
Journal:  ACS Biomater Sci Eng       Date:  2016-09-01

6.  Zein Microneedles for Transcutaneous Vaccine Delivery: Fabrication, Characterization, and in Vivo Evaluation Using Ovalbumin as the Model Antigen.

Authors:  Shubhmita Bhatnagar; Sumeet Rajesh Chawla; Onkar Prakash Kulkarni; Venkata Vamsi Krishna Venuganti
Journal:  ACS Omega       Date:  2017-04-06

Review 7.  Dissolving Microneedle Patches for Dermal Vaccination.

Authors:  M Leone; J Mönkäre; J A Bouwstra; G Kersten
Journal:  Pharm Res       Date:  2017-07-17       Impact factor: 4.200

Review 8.  Novel Pharmaceutical Strategies for Enhancing Skin Penetration of Biomacromolecules.

Authors:  Luyu Zhang; Zirong Dong; Wenjuan Liu; Xiying Wu; Haisheng He; Yi Lu; Wei Wu; Jianping Qi
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-16

9.  Coated and Hollow Microneedle-Mediated Intradermal Immunization in Mice with Diphtheria Toxoid Loaded Mesoporous Silica Nanoparticles.

Authors:  Guangsheng Du; Laura Woythe; Koen van der Maaden; Mara Leone; Stefan Romeijn; Alexander Kros; Gideon Kersten; Wim Jiskoot; Joke A Bouwstra
Journal:  Pharm Res       Date:  2018-08-13       Impact factor: 4.200

10.  Enhanced anti-tumor immunotherapy by dissolving microneedle patch loaded ovalbumin.

Authors:  Sung-Ju Lee; Hyeon-Seong Lee; Yun-Ho Hwang; Jong-Jin Kim; Kyung-Yun Kang; Seong Jin Kim; Hong Kee Kim; Jung Dong Kim; Do Hyeon Jeong; Man-Jeong Paik; Sung-Tae Yee
Journal:  PLoS One       Date:  2019-08-06       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.